Cigarette Sales Up in U.S. for the First Time in 20 Years

Intratumoral Dendritic Cells in Treatment of Lung Cancer

Studies Question Further Modification of pTNM Staging as 9th Edition Deadline Approaches

New Warranty, Rebate Programs Put Spotlight on Value in Lung Cancer

Rare NUT Carcinoma Gaining Recognition in Lung Cancer Community

Benefit to Pembrolizumab Observed in Previously Treated Malignant Pleural Mesothelioma Irrespective of PD-L1 Status

Assay that Combines Clinical, Radiomic Characteristics with CT Information Shown to Better Distinguish Malignant Early Lung Nodules

Comprehensive Analysis of Proteomics Identifies New, Druggable Drivers of NSCLC—and New Avenue for Continued Research

Atezolizumab Approved for Adjuvant NSCLC Therapy for Patients with Stage II-IIIA Disease, PD-L1 ≥ 1%

Toward More Inclusive, Accessible Clinical Trial Consent Forms

Spine Stereotactic Radiosurgery: A Critical Evaluation of the Evidence to Guide Clinical Practice